SLC44A2 and Venous thrombosis: Recent data reveal that SLC44A2-deficient mice exhibit normal hemostatic responses (Tilburg et al., 2018) but are protected against development of venous thrombosis (Tilburg et al., 2020), provide further encouragement for this strategy.